K
KRYS
Krystal Biotech
331.61
+4.31+1.32%After Hours: 331.61 0.00 0.00%19:30 10/09 EDT
OPEN/PREV CLOSE326.55/327.30
TODAY RANGE323.87-333.56
VOL196.96K
MARKET CAP9.82B
52 WEEK RANGE179.19-382.54
AVG VOL (3M)378.61K
% TURNOVER0.51%
TURNOVER--
P/E (TTM)41.58
% RANGE2.92%
EPS(TTM)7.98
P/E(FORWARD)44.67
P/B7.22
BVPS45.92
DIVIDEND--
P/S24.88
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP8.58B
SHARES OUTSTANDING29.60M
NEXT EARNINGS11/02-11/06
FREE FLOAT25.88M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·7h ago
Krystal Biotech: Vyjuvek's Success Is Becoming Its Growth Problem (Downgrade)
Seeking Alpha·10h ago
Krystal Biotech: My Analysis Suggests Stock Has Not Yet Reached Peak Value
Simply Wall St·2d ago
What Krystal Biotech (KRYS)'s VYJUVEK Sales Strength Means For Shareholders
Simply Wall St·3d ago
Krystal Biotech (KRYS) Could Be 17% Undervalued On Its Multiproduct Pipeline Story
Benzinga·09/25 21:30
Here's How Much $1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today
Simply Wall St·09/25 21:18
Krystal Biotech (KRYS) Stock Looks Stretched Against Current Earnings Power
Dow Jones·09/24 13:07
Krystal Biotech Price Target Announced at $441.00/Share by Goldman Sachs
Benzinga·09/24 12:56
Goldman Sachs Reinstates Buy on Krystal Biotech, Announces $441 Price Target
TipRanks·09/24 08:50
Krystal Biotech resumed with a Buy at Goldman Sachs
TipRanks·09/24 08:35
Goldman Sachs Resumes Coverage with a Buy Rating on Krystal Biotech (KRYS)
Dow Jones·09/21 17:51
Krystal Biotech Is Maintained at Buy by B of A Securities
Benzinga·09/21 17:41
B of A Securities Maintains Buy on Krystal Biotech, Raises Price Target to $400